Osteoporosis Management Flashcards

1
Q

What is the recommended calcium intake for premenopausal women and men?

A

1000–1200 mg/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the recommended calcium intake for postmenopausal women and men aged 65 and older?

A

1200–1500 mg/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the recommended vitamin D intake?

A

800–1200 IU/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What types of exercise are recommended for osteoporosis management?

A

Aerobic and resistance training

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What lifestyle modifications are suggested for osteoporosis management?

A
  • Limit alcohol to ≤2 drinks/day
  • Limit caffeine to ≤2 servings/day
  • Smoking cessation
  • Fall prevention
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What caution should be taken regarding calcium and vitamin D intake?

A

Excessive calcium/vitamin D may increase kidney stones and vascular calcifications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the calcium content estimates for dairy products?

A
  • Milk/Yogurt: 300 mg/cup
  • Cheese: 300 mg/oz
  • Calcium-fortified fruit juice: 300 mg/cup
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What should be added to estimate total calcium intake from nondairy sources?

A

Add 300 mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the best source of calcium?

A

Low-fat dairy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the difference between calcium carbonate and calcium citrate?

A
  • Calcium carbonate: Requires gastric acid; less effective with PPIs
  • Calcium citrate: Better for PPI users and kidney stone formers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the dietary sources of vitamin D?

A
  • Fatty fish (salmon, tuna, mackerel): D3 (400 IU/3.5 oz)
  • Fortified milk: 400 IU/quart
  • Sunlight: 10,000 IU in 10 minutes for fair-skinned individuals
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the goal serum 25-OH vitamin D level for deficiency treatment?

A

30–100 ng/mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the dosing for vitamin D based on serum levels?

A
  • 20–30 ng/mL: 2000 IU D3 daily
  • 10–20 ng/mL: 50,000 IU D2 weekly for 3 months, then 2000 IU D3 daily
  • <10 ng/mL: 50,000 IU D2 twice weekly for 3 months, then 2000 IU D3 daily
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What may require higher doses of vitamin D?

A

Malabsorption, liver disease, obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Is there an increased risk of coronary artery disease or vascular calcification with recommended doses of calcium and vitamin D?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the indications for initiating pharmacologic therapy for osteoporosis?

A
  • History of fragility fracture
  • T-score ≤-2.5 at any site
  • FRAX 10-year risk: ≥3% hip fracture or ≥20% major osteoporotic fracture
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the key processes involved in bone remodeling?

A
  • Osteoclasts resorb old bone
  • Osteoblasts form new bone (osteoid)
  • Osteocytes regulate remodeling via sclerostin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the role of RANK-L and OPG in bone metabolism?

A
  • RANK-L: Stimulates osteoclasts via RANK
  • OPG: Decoy receptor that inhibits RANK-L, reducing bone resorption
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are examples of antiresorptive agents?

A
  • Bisphosphonates
  • Denosumab
  • Estrogens
  • Raloxifene
  • Calcitonin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are examples of anabolic agents?

A
  • Teriparatide
  • Abaloparatide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the FDA-approved bisphosphonates?

A
  • Alendronate
  • Risedronate
  • Ibandronate
  • Zoledronic acid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the dosing schedule for Denosumab (Prolia)?

A

60 mg SQ every 6 months

23
Q

What is the dosing for Teriparatide?

A

20 mcg SQ daily

24
Q

What is the dosing for Abaloparatide?

A

80 mcg SQ daily

25
What is the mechanism of action of bisphosphonates?
Inhibit osteoclast activity by blocking farnesyl diphosphate synthase (FPPS)
26
What is the increase in bone mass due to bisphosphonates?
* Spine: 4–8% * Hip: 3–6%
27
What is the reduction in fracture risk with bisphosphonates?
* Vertebral fractures: 33–68% * Hip fractures: 40–50%
28
What are the administration requirements for oral bisphosphonates?
Take on empty stomach with water; remain upright for 30–60 minutes
29
What is the administration schedule for IV bisphosphonates?
Zoledronic acid: Yearly infusion
30
What are common side effects of bisphosphonates?
* Esophageal/GI pain * Osteonecrosis of the jaw (ONJ)
31
What is the mechanism of action of Denosumab?
Monoclonal antibody against RANK-L
32
What is the increase in BMD with Denosumab?
* Spine: 6.5% * Hip: 3.5%
33
What is the reduction in fracture risk with Denosumab?
* Vertebral fractures: 68% * Hip fractures: 40%
34
What occurs upon discontinuing Denosumab?
Rapid bone loss and vertebral fractures may occur
35
What are the risk factors for osteonecrosis of the jaw (ONJ)?
* Antiresorptive agents (bisphosphonates, denosumab)
36
What preventive measures should be taken for ONJ?
* Oral exam before starting therapy * Delay invasive dental work if possible
37
What are the risk factors for atypical femoral fractures (AFFs)?
Long-term antiresorptive therapy (>5 years)
38
What management strategy can reduce the risk of AFFs?
Drug holidays for bisphosphonates reduce risk by 70%
39
What is the duration limit for hormone replacement therapy (HRT)?
Limited to ≤3 years for postmenopausal symptoms
40
What are the risks associated with hormone replacement therapy (HRT)?
* Increased breast cancer * Cardiovascular events
41
What are the effects of Raloxifene as a selective estrogen receptor modulator (SERM)?
* Increases BMD by 2–3% * Reduces vertebral fractures by 31–49% * Reduces breast cancer risk by 76%
42
What are the effects of Teriparatide as an anabolic agent?
* Increases spine BMD by 9–13% * Increases hip BMD by 2.5–5% * Reduces vertebral fractures by 65% * Reduces nonvertebral fractures by 50%
43
What are the effects of Abaloparatide as an anabolic agent?
* Increases spine BMD by 10.4% * Increases hip BMD by 4% * Reduces vertebral fractures by 86% * Reduces nonvertebral fractures by 43%
44
What are the indications for testosterone therapy?
Men with osteoporosis and hypogonadism (testosterone <150 ng/dL)
45
What are the risks associated with testosterone therapy?
* Exacerbates prostate cancer * Sleep apnea * Cardiovascular risks
46
Is combination therapy of antiresorptive agents recommended?
Not recommended
47
What is the recommended sequence for therapy?
Anabolic agent first, followed by antiresorptive agent
48
How often should BMD testing be repeated?
Every 2 years
49
What indicates compliance and predicts bone mass increase in monitoring therapy?
30% reduction in bone turnover markers
50
What are the criteria for treatment failure?
* ≥2 fragility fractures * BMD decrease > LSC * Bone turnover markers increase by 30%
51
What is the treatment for glucocorticoid-induced osteoporosis (GIOP)?
* Bisphosphonates (alendronate, risedronate, zoledronic acid) * Teriparatide for high-risk patients
52
What are the risk stratification categories for GIOP?
* Low risk: FRAX <10% * Medium risk: FRAX 10–20% * High risk: FRAX >20%, T-score ≤-2.5, or fragility fracture
53
What are the key points in osteoporosis management?
* Nonpharmacologic measures are essential * Pharmacologic therapy for high-risk patients * Antiresorptive and anabolic agents are effective * Monitor for ONJ and AFFs with antiresorptive agents * Sequential therapy (anabolic → antiresorptive) is beneficial